- Supply TypeExporter, Supplier, Retailer, Distributor, Importer, Trader
- Preferred Buyer Location All over the world
MAVENCLAD is indicated as monotherapy for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) to reduce the frequency of clinical exacerbations and delay the progression of disability.
View More Details